DHC (Diversified Healthcare Trust): Time to Pay Attention?

After finishing at $0.76 in the prior trading day, Diversified Healthcare Trust (NASDAQ: DHC) closed at $0.78, up 2.02%. In other words, the price has increased by $+0.0154 from its previous closing price. On the day, 3419875 shares were traded. DHC stock price reached its highest trading level at $0.8100 during the session, while it also had its lowest trading level at $0.7620.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…



Our goal is to gain a better understanding of DHC by taking a closer look at its different ratios. In the meantime, Its Debt-to-Equity ratio is 1.13 whereas as Long-Term Debt/Eq ratio is at 1.13.

Upgrades & Downgrades

Wells Fargo Downgraded its Overweight to Equal Weight on January 17, 2020, while the target price for the stock was maintained at $9.

Valuation Measures:

As of this moment, Diversified’s Price-to-Earnings (P/E) ratio for their current fiscal year is 0.45. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.14. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.14 while its Price-to-Book (P/B) ratio in mrq is 0.07.

Stock Price History:

Over the past 52 weeks, DHC has reached a high of $3.28, while it has fallen to a 52-week low of $0.61. The 50-Day Moving Average of the stock is 0.8522, while the 200-Day Moving Average is calculated to be 1.5388.

Shares Statistics:

The stock has traded on average 4.04M shares per day over the past 3-months and 3.35M shares per day over the last 10 days, according to various share statistics. A total of 238.34M shares are outstanding, with a floating share count of 236.44M. Insiders hold about 0.10% of the company’s shares, while institutions hold 82.30% stake in the company. Shares short for DHC as of Oct 13, 2022 were 6.99M with a Short Ratio of 5.94M, compared to 9.22M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 2.92% and a Short% of Float of 4.59%.

Dividends & Splits

In the trailing 12 months, DHC’s forward annual dividend rate was 0.04, compared to 0.04 this year. Against a Trailing Annual Dividend Yield of 5.25%, it implies a Forward Annual Dividend Yield of 3.33%. The stock’s 5-year Average Dividend Yield is 7.31.

Earnings Estimates

Its stock is currently analyzed by 2 different market analysts. On average, analysts expect EPS of -$0.24 for the current quarter, with a high estimate of -$0.24 and a low estimate of -$0.25, while EPS last year was -$0.38. The consensus estimate for the next quarter is -$0.23, with high estimates of -$0.22 and low estimates of -$0.24.

Analysts are recommending an EPS of between $0.08 and $0.07 for the fiscal current year, implying an average EPS of $0.07. EPS for the following year is -$0.78, with 2 analysts recommending between -$0.77 and -$0.79.

Revenue Estimates

4 analysts predict $320.79M in revenue for the current quarter. It ranges from a high estimate of $324.68M to a low estimate of $315.64M. As of the current estimate, Diversified Healthcare Trust’s year-ago sales were $337.42M, an estimated decrease of -4.90% from the year-ago figure. For the next quarter, 4 analysts are estimating revenue of $328.53M, a decrease of -2.40% over than the figure of -$4.90% in the same quarter last year. There is a high estimate of $338.75M for the next quarter, whereas the lowest estimate is $320.96M.

A total of 4 analysts have provided revenue estimates for DHC’s current fiscal year. The highest revenue estimate was $1.29B, while the lowest revenue estimate was $1.26B, resulting in an average revenue estimate of $1.27B. In the same quarter a year ago, actual revenue was $1.38B, down -8.00% from the average estimate. Based on 4 analysts’ estimates, the company’s revenue will be $1.38B in the next fiscal year. The high estimate is $1.43B and the low estimate is $1.32B. The average revenue growth estimate for next year is up 8.50% from the average revenue estimate for this year.